Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TOP1 | P11387 | 5/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 4/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | APEX1 | P27695 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5437272 | 0.84 | KDM4E (0.60) | TOP1LMNAKDM4EALDH1A1HPGD | |
| SCHEMBL13799088 | 0.83 | KDM4E (0.42) | TOP1LMNAKDM4EALDH1A1HPGD | |
| SCHEMBL3976165 | 0.83 | KDM4E (0.59) | TOP1LMNAKDM4EALDH1A1HPGD | |
| SCHEMBL3976181 | 0.83 | KDM4E (0.59) | LMNAKDM4EALDH1A1HPGDHSD17B10 | |
| Hydrochloric Acid SCHEMBL3288212 | 0.82 | KDM4E (0.41) | TOP1LMNAKDM4EALDH1A1HPGD | |
| Hydrochloric Acid SCHEMBL4171813 | 0.82 | ALDH1A1 (0.44) | TOP1LMNAKDM4EALDH1A1HPGD | |
| Trifluoroacetic Acid SCHEMBL4180697 | 0.80 | RXRA (0.44) | TOP1LMNAKDM4EALDH1A1HPGD | |
| Trifluoroacetic Acid SCHEMBL4169384 | 0.79 | ALDH1A1 (0.46) | TOP1LMNAKDM4EALDH1A1HPGD | |
| Trifluoroacetic Acid SCHEMBL3982421 | 0.79 | KDM4E (0.55) | TOP1LMNAKDM4EALDH1A1HPGD | |
| Trifluoroacetic Acid SCHEMBL4180492 | 0.79 | KDM4E (0.43) | TOP1LMNAKDM4EALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090062218-A1 | MACROLONE COMPOUNDS | GLAXO GROUP LIMITED (GB) | 2009-03-05 | — | — | US | disclosed |
| EP-1824871-A1 | MACROLONE COMPOUNDS | GLAXO GROUP LIMITED (GB) | 2007-08-29 | — | — | EP | disclosed |
| WO-2006050940-A1 | MACROLONE COMPOUNDS | GLAXO GROUP LIMITED (GB) | 2006-05-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090062218-A1 | MACROLONE COMPOUNDS | CYP51A1, MRPL21, MYD88 | TOP1 596/4885LMNA 1055/4885KDM4E 3897/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.